• $768,669.00
    Market Cap
  • -98.44%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
-3,000
-115.00%
20,000
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-3,000
-115.00%
20,000
N/A
0
N/A
0
N/A
Sales and Marketing Expense
220,000
-73.24%
822,000
+8.30%
759,000
-14.53%
888,000
N/A
Research and Development Expense
-710,000
-65.55%
-2.1M
+9.34%
-1.9M
+32.84%
-1.4M
N/A
Depreciation and Amortization Expense
21,000
+23.53%
17,000
+70.00%
10,000
+100.00%
5,000
N/A
Total Operating Expenses
1.0M
-50.15%
2.0M
-4.25%
2.1M
+54.82%
1.4M
N/A
Operating Profit
-1.9M
-60.48%
-4.9M
+3.13%
-4.8M
+29.58%
-3.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-4,000
-20.00%
-5,000
-16.67%
-6,000
N/A
N/A
N/A
Interest Income and Expense and Net
-4,000
-20.00%
-5,000
-16.67%
-6,000
N/A
0
N/A
Total Nonoperating Income and Expense
-6,000
-400.00%
2,000
-92.86%
28,000
+168.29%
-41,000
N/A
Income before Taxes
-1.9M
-60.48%
-4.9M
+3.13%
-4.8M
+29.58%
-3.7M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.9M
-61.32%
-4.9M
+3.70%
-4.7M
+27.40%
-3.7M
N/A
Net Income from Continuing Operations Applicable to Common
-1.9M
-61.32%
-4.9M
+3.70%
-4.7M
+27.40%
-3.7M
N/A
Basic EPS and Net Income
-0.03
-57.14%
-0.07
0.00%
-0.07
+16.67%
-0.06
N/A
Diluted EPS and Net Income
-0.03
-57.14%
-0.07
0.00%
-0.07
+16.67%
-0.06
N/A
Basic Weighted Average Shares
69.4M
0.00%
69.4M
+2.70%
67.6M
+7.08%
63.1M
N/A
Diluted Weighted Average Shares
70.5M
+1.54%
69.4M
+2.70%
67.6M
+7.08%
63.1M
N/A
Balance Sheet
Cash and Cash Equivalents
129,000
-83.18%
767,000
-74.45%
3.0M
+6.64%
2.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
129,000
-83.18%
767,000
-74.45%
3.0M
+6.64%
2.8M
N/A
Total Current Assets
205,000
-75.83%
848,000
-72.26%
3.1M
+6.07%
2.9M
N/A
Accumulated Depreciation
58,000
+56.76%
37,000
+85.00%
20,000
+100.00%
10,000
N/A
Property and Plant and Equipment and Net
35,000
-37.50%
56,000
-21.13%
71,000
+129.03%
31,000
N/A
Total Long-Term Assets
46,000
-69.54%
151,000
-36.29%
237,000
+288.52%
61,000
N/A
Total Assets
251,000
-74.87%
999,000
-69.67%
3.3M
+11.93%
2.9M
N/A
Income Taxes Payable
88,000
+183.87%
31,000
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
157,000
-99.61%
40.5M
+101,112.50%
40,000
0.00%
40,000
N/A
Total Current Liabilities
545,000
+15.22%
473,000
-28.55%
662,000
+67.59%
395,000
N/A
Total Long-Term Debt
10.4M
N/A
N/A
N/A
40,000
N/A
N/A
N/A
Total Long-Term Liabilities
170,000
+5.59%
161,000
+302.50%
40,000
N/A
N/A
N/A
Total Liabilities
545,000
-14.04%
634,000
-9.69%
702,000
+22.73%
572,000
N/A
Retained Earnings
-16.7M
+12.80%
-14.8M
+49.44%
-9.9M
+91.11%
-5.2M
N/A
Total Stockholders Equity
-294,000
-180.55%
365,000
-85.92%
2.6M
+9.32%
2.4M
N/A
Total Shares Outstanding
71.0M
+1.54%
69.9M
+1.63%
68.8M
+6.51%
64.6M
N/A
Cash Flow
Cash from Operating Activities
-1.4M
-57.12%
-3.2M
-4.24%
-3.4M
+35.98%
-2.5M
N/A
Capital Expenditures
N/A
N/A
2,000
-96.00%
50,000
+61.29%
31,000
N/A
Cash from Investing Activities
N/A
N/A
-2,000
-96.61%
-59,000
-3.28%
-61,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
750,000
-25.00%
1.0M
-72.41%
3.6M
+3.84%
3.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
64,700.00%
+363.49%
-24,555.00%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-303.84%
+32.86%
-228.70%
+50.65%
-151.80%
N/A
N/A
N/A
Return on Equity
-5,349.30%
+1,511.11%
-332.03%
+74.04%
-190.77%
N/A
N/A
N/A
Revenue Growth
-115.00%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.38
-79.02%
1.79
-61.18%
4.62
N/A
N/A
N/A
Cash Ratio
0.24
-85.40%
1.62
-64.24%
4.53
N/A
N/A
N/A
Debt-to-Equity Ratio
-36.01
N/A
N/A
N/A
0.03
N/A
N/A
N/A
Debt-to-Assets Ratio
42.18
N/A
N/A
N/A
0.02
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow